INOVIO PHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
INOVIO PHARMACEUTICALS, INC. (INO) had Accumulated Other Comprehensive Income of -$279.98 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-12
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$279.98K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$636.09K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$637.96K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$647.36K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$279.98K 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$636.09K 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$637.96K 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$647.36K 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$661.74K 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$661.32K 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$675.67K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$623.46K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$689.54K 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$676.21K 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$662.60K 10-K · filed 2025-03-18 |
| 2023-09-30 | -$751.07K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$691.26K 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$582.80K 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$698.74K 10-K · filed 2024-03-06 |
| 2022-09-30 | -$885.21K 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$649.66K 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$457.89K 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$282.24K 10-K · filed 2023-03-01 |
| 2021-09-30 | -$257.93K 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$265.91K 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$265.71K 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$256.15K 10-K · filed 2022-03-01 |
| 2020-09-30 | -$247.83K 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$610.03K 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$1.46M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $472.61K 10-K · filed 2021-03-01 |
| 2019-09-30 | $700.40K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $731.86K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $290.31K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$528.87K 10-K · filed 2020-03-12 |
| 2018-09-30 | -$281.76K 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$598.39K 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$461.14K 10-Q · filed 2018-05-09 |
| 2018-01-01 | -$348.37K 10-K · filed 2019-03-12 |
| 2017-12-31 | -$117.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $559.66K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.18M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $781.55K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.33M 10-K · filed 2018-03-14 |
| 2016-09-30 | $2.66M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $3.51M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $2.91M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $2.71M 10-K · filed 2017-03-15 |
| 2015-09-30 | $3.65M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$324.19K 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$191.52K 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$251.39K 10-K · filed 2016-03-14 |
| 2014-09-30 | -$110.18K 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$47.36K 10-Q · filed 2014-08-11 |
| 2014-03-31 | -$71.81K 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$76.36K 10-K · filed 2015-03-16 |
| 2013-09-30 | -$98.02K 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$96.44K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $66.52K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $73.36K 10-K · filed 2014-03-17 |
| 2012-09-30 | $93.10K 10-Q · filed 2012-11-07 |
| 2012-06-30 | $64.51K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $65.01K 10-Q · filed 2012-05-09 |
| 2011-12-31 | $35.39K 10-K · filed 2013-03-18 |
| 2011-09-30 | -$5.21K 10-Q · filed 2011-11-07 |
| 2011-06-30 | -$2.94K 10-Q · filed 2011-08-05 |
| 2010-12-31 | $2.85K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |